Honestly slim, stick to the charts. The recent drop is easily attributable to lower than expected Daybue sales. Not lack of interest due to our 'fantastic growth.' I'm very hopeful of things turning around with upcoming FDA meetings and the phase 2 outcomes we have had. But to say that our SP drop is due to reduced interest despite 'fantastic growth' whilst ignoring the fact that we missed guidance is head in sand behaviour. I would love you to post a chart of what typically happens to a company when guidance is missed..
After yesterday I have never been more optimistic about our future!
Honestly slim, stick to the charts. The recent drop is easily...
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.76 |
Change
0.150(1.10%) |
Mkt cap ! $1.758B | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.00 | $13.51 | $5.043M | 365.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3816 | $13.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.78 | 2834 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |